Antibody persistence at 18–20months of age and safety and immunogenicity of a booster dose of a combined DTaP–IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China

Vaccine ◽  
2011 ◽  
Vol 29 (50) ◽  
pp. 9337-9344 ◽  
Author(s):  
Rong Cheng Li ◽  
Feng Xiang Li ◽  
Yan Ping Li ◽  
Qi Ming Hou ◽  
Chang Gui Li ◽  
...  
Keyword(s):  
Booster Dose ◽  
Primary Vaccination ◽  
People’S Republic Of China ◽  
People's Republic Of China ◽  
Republic Of China ◽  
Antibody Persistence ◽  
Healthy Infants
Sign in / Sign up

Export Citation Format

Share Document